Taken together, our data reveal an unforeseen biological interaction between GR-regulated transcription and EZH2-mediated chromatin remodeling, which suggest potential new avenues for clinical investigation in patients with therapy resistant NHL. The gene discussed is EZH2; the disease is non-Hodgkin lymphoma.